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ABSTRACT
Objective: This study aimed to determine the effects of indoor air pollution on workers and the effects of discharged gases, such as CO, CO2, NO2, O3, 
SO2, NH3, and PM, on the manifestation of bronchial reactivity during the process of gasification at the power plants in Kastriot, Kosovo.
Methods: Parameters of lung function were determined using body plethysmography. Airway resistance (Raw) and intrathoracic gas volume (ITGV) 
were measured; based on these values, specific airway resistance (SRaw) and specific airway conductance were calculated.
Results: The study was performed in two groups: the control group and the experimental group. The control group consisted of 32 healthy people, 
whereas the experimental group consisted of 55 workers of the gasification department of the power plants in Kastriot, Kosovo. The results of this 
study indicated that the mean value of SRaw significantly increased in the experimental group (p<0.05) compared to the control group (p>0.1). This 
study also showed that smoking is in favor of the negative effects of air pollution at the premises of the gasification department (p<0.01). Measurements 
of the respiratory systems were made before and following provocation with histamine–aerosol (1 mg/ml) in the control and experimental groups. 
Changes between these two groups following this provocation with histamine–aerosol were found to be statistically significant (p<0.01).
Conclusion: Although air pollution requires time to cause a respiratory pathology, it permanently affects the manifestation of bronchial reactivity. 
This finding suggests that the real situation of these workers exposed to air pollution during the process of gasification poses a serious risk to their 
health and particularly to normal respiratory function.
Keywords: Power plants of Kosovo, Workers during the process of gasification, Respiratory health.
INTRODUCTION
Air pollution has been a long time problem, but only in recent decades, 
it has been given relevant importance. Although numerous studies in 
this field have been reported, questions regarding the relationship 
between pathological changes and the deleterious effect of nitrogen 
oxide (NOx) in the workplace remain [1]. 
The effect of NOx causes hyperemia, edema, and hypertrophy of the 
bronchial mucosa, increased secretion of the glandular apparatus, and 
bronchial musculature tonus, which certainly causes damage to the 
ventilatory function of the lungs [2]. Chronic obstructive pulmonary 
disease (COPD) is one of the leading causes of death and disability 
worldwide. According to the WHO forecasts, COPD will become the 
fourth leading cause of mortality in the world by 2030 [3]. 
The main gaseous pollutants released during the gasification process by 
power plants are carbon monoxide and dioxide (CO and CO2), nitrogen 
dioxide (NO2), ozone (O3), and sulfur dioxide (SO2). Other important 
gaseous pollutants are ammonia and volatile organic compounds (e.g., 
methane, benzene, and chlorofluorocarbon) [4].
Air pollution has become the leading environmental cause of premature 
deaths [5]. Global estimates show that external pollution and indoor 
environments cause 1.15 million deaths worldwide (corresponding to 
nearly 2% of the total death toll) [6]. 
The harmful effects of O3, NO2, and particulate matter (PM), as well as 
the pollution of the traffic, in general, on respiratory symptoms and 
functions, are well documented. In addition to strong epidemiological 
evidence of a link between air pollution and asthma, recent studies, 
especially in urban areas, have shown the role of pollutants in the 
development of asthma and COPD [7,8]. 
Air pollution can also increase the risk of pneumonia by impairing the 
function of alveolar pulmonary macrophages and epithelial cells [9]. 
The interaction of air pollutants and their effect on bronchial 
hyperreactivity indicate that SO2 and O3 increase bronchial 
hyperreactivity. SO2 concentrations up to 0.5 ppm and O3 concentrations 
up to 0.2 ppm have shown this effect [10].
Studies have shown that respiratory obstruction and increased 
bronchial reactivity are present in the early lives of children who 
develop asthma [11]. 
Exposure to air pollution has been associated with increased 
cardiovascular disease (CVD), and the biological mechanism of oxidative 
stress and systemic inflammation plays an important role. Heart rate, 
systolic blood pressure, diastolic blood pressure, white blood cells, red 
blood cells, hematocrit, and hemoglobin are several biomarkers of CVD-
related oxidative stress and systemic inflammation [12]. 
Air pollution poses a potential risk for increased lung cancer risk. 
The link between exposure to air pollution at work and lung cancer 
risk indicates that long-term exposure to workplace environmental 
pollution can cause lung cancer [13]. 
Oral, pharyngeal, and laryngeal cancers are linked to smoking and may 
also be linked to other sources of air pollution [14]. 
© 2020 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
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In Kosovo, the air quality has severely deteriorated in developed urban 
areas, especially in industrial power plants. The greatest impact on the 
environment is caused by Kosovo Energy Corporation power plants 
(TC-A and TC-B), industries (releasing gases at workplaces, surface 
mines, cement plants, etc.), and small ones. Pollution, however, is also 
caused by individual heating facilities [15].
On this basis, the essential purpose of our study is to compare the 
bronchial reactivity between healthy individuals and those exposed 
to high levels of gas-polluted air pollution in the workplace during 
the gasification process in Kosovo’s power plants. The most direct air 
pollution damage is, undoubtedly, reflected in the respiratory system; 
thus, all our study is focused on this system.
METHODS
Our study focused on detailed research to validate all cases verified with 
increased bronchial reactivity and COPD by examining the respiratory 
system as per the Medical Research Council (MRC) [16] questionnaire 
for COPD by recording the degree of pulmonary function impairment. 
Hence, we have ascertained the phenomenon of increased bronchial 
reactivity and COPD by measuring the objective parameters of the 
workers of the gasification department in the Kosovo power plants. 
Research at workplaces with exposure to different gases shows large 
differences in the prevalence of increased bronchial reactivity and 
obstructive pulmonary disease such as different habits, smoking, 
working conditions, and workplaces.
Smoker and nonsmoker plethysmography values of the examined 
workers indicate an increasing tendency with increasing age and 
duration of exposure to harmful NOx in the workplace. It is important to 
note that there are statistically significant differences between smokers 
and nonsmokers. There are also statistically significant differences in 
these values compared to those of individuals suffering from chronic 
obstructive bronchitis and those without chronic obstructive bronchitis, 
which reduces the relevance of the MRC questionnaire [17].
The individual selection was randomized, and all research participants 
were informed about the procedures and purpose of the research. 
All individuals who were part of the research were informed in advance 
to not administer any drugs at least 48 h before the examination to 
avoid interference with our test results. Thus, pulmonary functions 
are determined in tranquility. Specific airway resistance (SRaw) and 
intrathoracic gas volume (ITGV) measurements were then measured 
using body plethysmography. Based on the SRaw and ITGV values 
obtained, airway resistance (Raw) and specific airway conductance 
(SGaw) were calculated. 
In the control group, we also applied an additional procedure to verify 
that the selected individuals were indeed healthy and did not possess 
bronchial reactivity in the respiratory tract airways. We demonstrated 
this by performing a bronchoconstriction provocation test with 
bronchoconstriction agents such as histamine. In our case, we have 
used histamine for airway constriction. 
Relatively large numbers of patients are due to the interaction of many 
factors such as poor climatic conditions in the workplace, smoking, 
poor socioeconomic conditions, and inadequate medical care.
The research was carried out in two working groups: The control group 
and the experimental group. The control group included 32 healthy 
people, whereas the experimental group included 57 workers, with 
permanent work in the gasification process department at power 
plants in Kastriot, Kosovo. 
Plethysmography is sophisticated equipment that measures 
the volume of air in the sternum. This equipment consists of a 
plastic booth dedicated to the individual entering to perform the 
measurements. Subject blows into a turbine, which, like spirometry, 
records the volumes and airflows that this subject performs. Using 
plethysmography, we can record the pressure-pressure curves as 
well as the pressure-flow curves. Calculate the ratios between cabin 
air pressures and airway pressures, and the pressure-flow curve is 
calculated as the ratio between the pressure in the booth and airflow in 
the airways. The main parameters we measure using a plethysmograph 
are the volumes of gases in the sternum, namely, ITGV. Hence, the 
volumes of air in the respiratory system can be calculated as well as 
the amount of air remaining in the alveolar cysts. Other very important 
parameters that are measured using a plethysmograph are the airway 
resistance (Raw). These are calculated by the pressure difference at 
the beginning and end of the airway when the flow passing through 
them is 1 l/s. These parameters indicate the level of obstacle faced by 
the air when breathing (inspirium-expirium). SRaw is calculated as 
the ratio between Raw and ITGV. Another parameter is SGaw, which 
represents the ratio of 1/SRaw.
If changes in the respiratory system are found, an appropriate treatment 
with drugs is initiated immediately. Drugs used to treat bronchial 
asthma and COPD was: 
a. Bronchodilator and
b.	 Anti-inflammatory	drugs
Bronchodilator drugs: Beta-2 adrenergic agonists, methylxanthines, 
and anticholinergic drugs [18-20].
Anti-inflammatory drugs: Corticosteroids, antihistamines, and 
antileukotrienes [21-23].
As medical treatment of these diseases is limited, the only option is to 
take preventive measures [24-26].
This scientific study is about the difference between the two research 
groups. On this basis, we used the t-test as a differentiation mechanism 
regarding the level of significance between the two groups: The control 
group and the experimental group (gasification department workers). 
In the control group, we have two sets of plethysmography values, 
which were obtained as a result of pre- and post-provocation histamine 
measurements of individuals in the same group. 
Statistical processing involves the determination of mean (X), standard 
deviation (SD), and standard error of the mean, as well as testing of 
statistical differences between workers and control group. Statistical 
method ANOVA was used for analysis. The ANOVA test was used to 
analyze the differences between the results obtained within the group. 
The parameters are summarized in MS-EXCEL. The results obtained 
were tested using Student’s t-test to ascertain significant differences 
between the experimental and control groups. Statistical software 
INSTAT-3 and STATISTICA for Windows have been used. 
RESULTS
We believe that the tracheobronchial system showed no sensitivity in 
healthy individuals; therefore, they can be used as a special control 
group to evaluate the condition of the experimental group. General 
data of the individuals of both groups are given in Tables 1 and 2 and 
Diagram 1.
Initially, we present the plethysmography results of the control group 
to avoid suspicions about the presence of bronchial reactivity in this 
group. These results are expressed in two series, before and after 
provocation with histamine bronchoconstriction test (Fig. 1).
Statistical calculation with a t-test shows no significant difference 
(p>0.1) in healthy individuals before and after provocation with 
histamine. The SRaw and SGaw between the control and experimental 
groups were significantly different (p<0.05). The results show a 
pronounced presence of bronchial reactivity of workers who worked on 
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the gasification process in Kosovo’s power plants. The values of SRaw 
and SGaw for the research groups are shown in Figs. 2 and 3.
DISCUSSION
There is comprehensive literature on the health effects of gas pollutants 
in the workplace, including numerous epidemiological and toxicological 
studies. In each special study, there is a relationship between gaseous 
air pollution in the workplace and one or more other factors, depending 
on the level of exposure, the health status of the workers exposed, and 
their age. 
Scientific evidence on the health effects of gaseous air pollution at 
workplaces has been increasing in recent years. Some questions remain 
open, but many epidemiological studies have shown the importance 
of air pollution in workplaces as a risk factor for their mortality and 
morbidity [27]. The impact of air pollutants on the respiratory tract has 
been widely and consistently reported in recent years [28]. 
Air pollution has broad systemic effects on the human body, affecting 
both the respiratory and cardiovascular systems through multiple 
mechanisms, including oxidative stress, inflammation, and endothelial 
dysfunction [29]. The correlation between air pollution and 
cardiorespiratory diseases is a global concern [30]. 
Statistical calculation of SRaw and SGaw was performed for the control 
and experimental group, indicating a significant difference between 
these groups (p<0.05). The presence of emphasized bronchial reactivity 
in the workers working in the gasification department at the Kosovo 
power plants has been registered.
The difference between the experimental subgroups confirmed the 
favorable impact of smoking on exacerbating the negative respiratory 
effects of air pollution at the gasification department of the power plant 
(p<0.01). 
Due to indoor ventilation, employees who work indoors are subjected 
to the elimination of gases released by the ventilation system during 
the gasification process. The workers were less affected from bronchial 
reactivity than the residents who live near power plants as these workers 
leave the environment where they work after 8 h of work and travel farther 
away from the power plants where they live (up to 50 km away), with less 
air pollution or no pollution at all. This may also be the cause for lower 
susceptibility of bronchial reactivity in these workers (p<0.05) compared 
to residents who live near the power plants and are, therefore, constantly 
exposed to irritants for 24 h, which is manifested with emphasized 
bronchial reactivity (p<0.01), greatly endangering health [31].
In addition to cardiopulmonary morbidity and mortality, recent studies 
have found that air pollution is also associated with health effects, 
such as dementia, structural brain changes in children, cognitive 
impairments, and diabetes [32]. 
There is strong evidence that air pollution with different gases in the 
workplace exacerbates asthma morbidity and mortality in individuals 
with the disease and there is some evidence that air pollution with 
gases may affect asthma prevalence [33]. Children are at greater risk 
of developing asthma when exposed to higher concentrations of air 
pollutants [34]. 
A study carried out in continental France found that 9% of total 
mortality in France is due to anthropogenic PM2.5 [35]. The calculated 
total mortality for PM2.5 is higher than that due to PM10 [36].
The American Heart Association published a “Scientific Statement” 
stating that “there is a correlation between PM2.5 exposure and mortality 
– cardiovascular morbidity” [37].
In addition, a new health outcome in the United States showed that the 
incidence of lung cancer is related to exposure to PM2.5 particles [38]. 
Table 2: Body-plethysmography features of individuals involved 
in the study
Group n Raw 
(kPa×s/L) 




Control 32 0.17±0.5 3.05±0.3 0.51±0.3 1.96±0.13 
Experimental 55 1.15±0.7 3.55±0.6 4.08±0.8 2.24±0.18 
Raw (kPa×S/L); ITGV (L); SRaw: Raw×ITGV; SGaw: 1/SRaw, Raw: Airway 
resistance expressed in kilopascal/s/liter, ITGV: Volume of intrathoracic gas 
expressed in liters, SRaw: Specific airway resistance, which is the relationship 
between resistance and the volume of intrathoracic gas, SGaw: Expresses the 
relationship between 1/specific resistances. SGaw can also be referred to as 
specific airway passage or conductivity
Table 1: General characteristics of the subjects
Group n Age (years) Height (cm) Weight (kg) VC (L) FEV1 (L)
Control 32 22.8±0.45 175±0.37 68.5±1.8 3.80±0.12 3.82±0.12
Experimental 55 38.54±1.33 175.67±0.54 70.80±1.22 3.90±0.11 3.68±0.12
Generalized mean values for: Control group n=32, X±standard error of the mean; Experimental group n=55, X±standard error of the mean. The general starting values 
for VC (L) and FEV1 (L) are also given. VC: Vital capacity expressed in liters, FEV1: Enhanced expiratory volume in the 1st s, expressed in liters
Diagram 1: People’s participation frequency of the control and 
experimental group in the experiment
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In the American Cancer Society study, the incidence of lung cancer 
increased by 8% for 10 μg×m−3 increases in PM2.5 levels measured 
between cities [39]. PM2.5 was also associated with decreased 
parathyroid hormone in exposed individuals [40]. 
In addition to CO and CO2, other pollutants, including NO2 and O3, 
were also associated with workplace mortality [41]. SO2 has also been 
associated with increased mortality and morbidity. Significant effects of 
SO2 and cardiopulmonary mortality have been observed [42]. 
NO2 concentrations are related to mortality rate and mortality is caused 
by cardiovascular and respiratory morbidity and lung cancer [43]. 
According to a study conducted in Copenhagen, Denmark, reducing 
NO2 exposure by reducing traffic-related air pollution will reduce the 
incidence and prevalence of chronic CVD, respiratory, and lung cancers, 
thereby increasing life expectancy [44]. 
A study was conducted to ascertain the link between O3 and mortality in 
21 European cities and found that the 10 ppb increase in the 2-day 8-h O3 
average was 0.31% (95% confidence interval [CI]: 0.17%, 0.52 %), 1.13% 
(95% CI: 0.74%, 1.51%), and 0.46% (95% CI: 0.22%, 0.73%) increase in 
total respiratory and cardiovascular mortality in summer [45]. 
Acute and inflammatory changes caused by sudden exposure to 
high concentrations of irritating gas or steam are associated with 
bronchoconstriction, manifested by dyspnea, and chest pain. Chronic 
inflammatory changes caused by constant or intermittent effects of 
moderately increased concentrations of soluble (HCl, SO2, NH3, and 
the like) or less soluble irritants (O3, NOx, etc.) have been associated 
with variable airway reactivity. Different gases through their chlorides 
and carbon-containing compounds cause changes throughout the 
bronchial trunk and reversible bronchoconstriction that can be 
measured. The markedly increased trunk reactivity of the airways 
causes exposure to proteolytic enzymes. The inflammatory process 









Raw 0.12 0.13 1.5 3.15
ITGV 2.85 3.15 2.85 2.75
SRaw 0.34 0.41 4.27 8.66






























Fig. 1: Control and experimental group before and after provocation. Comparison of values of specific airway resistance and 
specific airway conductance in between the control group (p>0.1; n=32; X±standard error of the mean) and experimental group 
(n=55; X±standard error of the mean). (p<0.05)
Raw ITGV SRaw SGaw
Total 0.12 3.55 4.26 0.23
Non-smokers 1.2 3.4 4.08 0.24


























Fig. 2: Researched by non-smoker and smoker categories (before provocation with histamine). Comparison of specific airway resistance 
and specific airway conductance values between smokers and non-smokers before provocation with histamine (n=55; X±standard error 
of the mean; (p<0.05)
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of activated alveolar macrophages, neutrophils, cytotoxic CD8+T 
lymphocytes, B lymphocytes, CD4+T lymphocytes, and the release of 
numerous inflammatory mediators (leukotrienes, cytokines, growth 
factors, chemokines, and oxidants). Chronic inflammation leads to a 
reconfiguration of small airways with lumen blockage due to increased 
mucus production and thickening of the airway walls due to edema and 
collagen formation, causing fibrosis and constriction [46]. 
Based on the research and results obtained, it can be concluded 
that continuous monitoring of the respiratory tract is necessary, 
especially because of the presence of an inflammatory reaction that 
occurs after prolonged exposure to the pollutant. These workers 
must undergo systemic visits and tracheobronchial provocation 
tests with histamine or methacholine, which is valuable for timely 
therapeutic intervention. Subjects with bronchial hyperreactivity 
show a special preference for the rapid onset of permanent changes 
in the respiratory tract, which is why they should be distinguished as 
subjects at higher risk.
CONCLUSION
These studies indicate undoubtedly that long-term exposure of 
workers at the gasification department of power plants in Kosovo to 
harmful gases such as carbon monoxide, carbon dioxide, sulfur dioxide, 
sulfur trioxide, NOx, soot, and other pollutants in the workplace cause 
the occurrence of respiratory tract inflammation with the release of 
chemical mediators manifested by bronchial hyper-reactivity. 
Determining the value of the reaction against the inhalation of 
histamine hydrochloride resulted at a higher percentage of increase 
of bronchial reactivity, which is expressed with the increase in specific 
resistance (SRaw) and SGaw in groups exposed to toxic gases (p<0.05) 
in comparison to control group (p>0.1).
Experimental group, as an entirety, and subgroup of smokers indicate 
about significant changes in the SRaw and SGaw (p<0.05) in the airways 
compared to the control group (p>0.1). The difference between the 
experimental subgroups confirmed the favorable impact of smoking in 
exacerbating the negative respiratory effects of air pollution (p<0.01). 
Based on the research and the results obtained, it can be concluded that 
permanent monitoring of the respiratory tract is required, especially 
from the point of view of the presence of inflammatory reaction 
following prolonged exposure to environmental pollutants. People with 
increased bronchial hyperreactivity indicate a special predisposition 
for a quick manifestation of permanent changes in the respiratory tract, 
and this is just the reason of why they can be singled out as subjects 
with the highest riskiness.
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